Related Articles
Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status